EMEA-002756-PIP01-19-M01
Key facts
| Active substance |
sotatercept
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0414/2022
|
| PIP number |
EMEA-002756-PIP01-19-M01
|
| Pharmaceutical form(s) |
Powder for solution for injection
|
| Condition(s) / indication(s) |
Treatment of pulmonary arterial hypertension
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Merck Sharp & Dohme B.V.
Tel. +33 180464738 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|